Lingyao Du

759 total citations
60 papers, 489 citations indexed

About

Lingyao Du is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Lingyao Du has authored 60 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 47 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in Lingyao Du's work include Liver Disease Diagnosis and Treatment (38 papers), Hepatitis B Virus Studies (30 papers) and Hepatitis C virus research (29 papers). Lingyao Du is often cited by papers focused on Liver Disease Diagnosis and Treatment (38 papers), Hepatitis B Virus Studies (30 papers) and Hepatitis C virus research (29 papers). Lingyao Du collaborates with scholars based in China, United States and Spain. Lingyao Du's co-authors include Hong Tang, Lang Bai, Hong Tang, Libo Yan, En‐Qiang Chen, Lingyun Zhou, Duoduo Lv, Yuanji Ma, Meng-Lan Wang and Shu Feng and has published in prestigious journals such as Hepatology, Scientific Reports and Frontiers in Microbiology.

In The Last Decade

Lingyao Du

58 papers receiving 484 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lingyao Du 314 286 119 55 54 60 489
Zhiliang Gao 311 1.0× 303 1.1× 104 0.9× 43 0.8× 43 0.8× 59 520
Pamela Valva 250 0.8× 225 0.8× 74 0.6× 49 0.9× 25 0.5× 24 399
Yunjie Dan 185 0.6× 183 0.6× 45 0.4× 41 0.7× 37 0.7× 18 339
Chenghong Yin 120 0.4× 150 0.5× 130 1.1× 25 0.5× 42 0.8× 27 461
Honglian Gui 340 1.1× 306 1.1× 55 0.5× 107 1.9× 14 0.3× 27 494
Yongbin Zeng 222 0.7× 147 0.5× 121 1.0× 31 0.6× 18 0.3× 31 330
Yong Kwang Park 209 0.7× 150 0.5× 94 0.8× 48 0.9× 24 0.4× 16 319
Rachelle Boulton 241 0.8× 136 0.5× 89 0.7× 37 0.7× 17 0.3× 18 493
Thomas London 386 1.2× 285 1.0× 74 0.6× 35 0.6× 39 0.7× 10 518
Chih‐Feng Wu 330 1.1× 266 0.9× 78 0.7× 46 0.8× 27 0.5× 9 451

Countries citing papers authored by Lingyao Du

Since Specialization
Citations

This map shows the geographic impact of Lingyao Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyao Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyao Du more than expected).

Fields of papers citing papers by Lingyao Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyao Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyao Du. The network helps show where Lingyao Du may publish in the future.

Co-authorship network of co-authors of Lingyao Du

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyao Du. A scholar is included among the top collaborators of Lingyao Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyao Du. Lingyao Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ma, Yuanji, Lingyao Du, Lang Bai, & Hong Tang. (2025). Association between lactate-to-albumin ratio and all-cause mortality in critically ill cirrhotic patients with sepsis: a retrospective analysis of the MIMIC-IV database. BMC Gastroenterology. 25(1). 112–112. 1 indexed citations
3.
Liu, Changhai, Fang Chen, Qi Yang, et al.. (2025). Association Between Artificial Liver Support System and Prognosis in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Infection and Drug Resistance. Volume 18. 113–126. 1 indexed citations
4.
Ma, Yuanji, Yan Xu, Lingyao Du, Lang Bai, & Hong Tang. (2024). Association between systemic immune inflammation index and short term prognosis of acute on chronic liver failure. Scientific Reports. 14(1). 21535–21535. 3 indexed citations
5.
Shang, Jin, Lingyao Du, Weiwei Huang, et al.. (2024). RNA‐binding protein Trx regulates alternative splicing and promotes metastasis of HCC via interacting with LINC00152. Journal of Gastroenterology and Hepatology. 39(12). 2892–2902. 2 indexed citations
7.
Ma, Yuanji, et al.. (2024). Association between lactate-to-albumin ratio and short-term prognosis of acute-on-chronic liver failure treated with artificial liver support system. European Journal of Gastroenterology & Hepatology. 37(3). 327–336. 1 indexed citations
8.
Huang, Wei, et al.. (2024). The potential therapeutic role of melatonin in organ fibrosis: a comprehensive review. Frontiers in Medicine. 11. 1502368–1502368. 2 indexed citations
9.
Ma, Yuanji, Jiayi Wang, Lingyao Du, & Hong Tang. (2024). Association between the systemic immune-inflammation index and the outcome of liver fibrosis in patients with chronic hepatitis C. Frontiers in Medicine. 11. 1486503–1486503.
11.
Wang, Ming, Yuanji Ma, Lingyao Du, Hong Tang, & Lang Bai. (2021). Association between longer duration of citrate accumulation and 90-day mortality of acute-on-chronic liver failure. Critical Care. 25(1). 387–387. 2 indexed citations
12.
Shi, Ying, Lingyao Du, Duoduo Lv, et al.. (2021). Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases. Journal of Gastroenterology. 56(4). 336–349. 40 indexed citations
13.
Yu, Youjia, Lingyao Du, Cong Liu, et al.. (2017). Hepatitis B virus X protein promotes hepatocellular carcinoma invasion and metastasis via upregulating thioredoxin interacting protein. Oncology Letters. 14(2). 1323–1332. 17 indexed citations
14.
Shang, Jin, Libo Yan, Lingyao Du, et al.. (2017). Recent trends in the distribution of causative diseases of fever of unknown origin. Wiener klinische Wochenschrift. 129(5-6). 201–207. 7 indexed citations
16.
Wang, Meng-Lan, Qiaoling Zhou, En‐Qiang Chen, et al.. (2016). Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg Seroconversion. Viral Immunology. 29(6). 332–342. 5 indexed citations
17.
Yan, Libo, et al.. (2016). Quantitative intrahepatic HBV cccDNA correlates with histological liver inflammation in chronic hepatitis B virus infection. International Journal of Infectious Diseases. 52. 77–82. 18 indexed citations
18.
Tang, Hong, En‐Qiang Chen, Lanlan Chen, et al.. (2015). Serum hepatitis B surface antigen titer and transient elastography in screening for insignificant fibrosis in HBeAg-positive chronic hepatitis B patients. Therapeutics and Clinical Risk Management. 11. 229–229. 5 indexed citations
19.
Du, Lingyao, Yao‐Li Cui, En‐Qiang Chen, et al.. (2014). Correlation between the suppressor of cytokine signaling-1 and 3 and hepatitis B virus: possible roles in the resistance to interferon treatment. Virology Journal. 11(1). 51–51. 14 indexed citations
20.
Yan, Libo, En‐Qiang Chen, Lang Bai, et al.. (2014). Efficacy of entecavir treatment for up to 96 weeks in nucleoside-naive HBeAg-positive chronic hepatitis B patients with high viral load. Clinics and Research in Hepatology and Gastroenterology. 39(3). 366–372. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026